世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のmRNA生酵素市場レポート、歴史と予測2019-2030年


Global mRNA Raw Enzyme Market Report, History and Forecast 2019-2030

mRNA生酵素の世界市場は、2023年に1億7,671.10万米ドルと推定され、2024年から2030年の予測期間中にCAGR 1.42%で成長し、2030年には17億3,122万米ドルに達すると予測されています。 mRNA生酵素の北米市場は、202... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年6月18日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

mRNA生酵素の世界市場は、2023年に1億7,671.10万米ドルと推定され、2024年から2030年の予測期間中にCAGR 1.42%で成長し、2030年には17億3,122万米ドルに達すると予測されています。
mRNA生酵素の北米市場は、2023年に6億4,010万ドルと評価され、2024年から2030年の予測期間中に-0.67%のCAGRで、2030年までに6億1,493万ドルに達すると予測される。
mRNA生酵素のアジア太平洋市場は、2023年に3億6,791万ドルと評価され、2024年から2030年の予測期間中に4.83%のCAGRで、2030年までに4億6,847万ドルに達するだろう。
mRNA生酵素のヨーロッパ市場は、2023年に5億9,233万ドルと評価され、2024年から2030年の予測期間中に1.44%のCAGRで、2030年までに5億6,594万ドルに達するだろう。

当レポートは、mRNA生酵素の世界市場を量的・質的分析の両面から包括的に紹介することで、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、mRNA生酵素に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。
市場をより深く理解するために、本レポートでは競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。
本レポートは、読者が潜在的な利益を高めるために、業界内の競争と競争環境に対する戦略を理解するのに役立ちます。また、世界のmRNA生酵素市場の競争環境に焦点を当て、主要企業の市場シェア、業界ランキング、競合エコシステム、市場実績、新製品開発、経営状況、事業拡大、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解するのに役立ちます。

市場区分
本レポートでは、mRNA生酵素の企業別、タイプ別、用途別、地域別、国別のセグメントを網羅し、2023年を基準年とした過去および予測期間(2019-2024年、2025-2030年)の市場規模およびCAGRを提供しています。さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリックスについて解説しています。

企業別
サーモフィッシャー
NEB
トライリンク・バイオ・テクノロジーズ
メルク
アルデブロン
Qiagen N.V.
プロメガ
ロシュ・カスタムバイオテック
タカラバイオ
ノボプロテイン
バザイム
ホンジェンバイオテック
イェーセンバイオテクノロジー(上海)
カクタスバイオシステムズ

タイプ別
キャッピング酵素
2'-O-メチルトランスフェラーゼ
無機ピロホスファターゼ
ポリ(A)ポリメラーゼ
Rnaseインヒビター
RNAポリメラーゼ
制限酵素
ドナーゼI
その他

用途別セグメント
バイオ製薬会社
学術・研究機関

地域別
北米
米国
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
インド
オーストラリア
東南アジア
アジア太平洋 その他

ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ヨーロッパ その他

ラテンアメリカ
ブラジル
アルゼンチン
ラテンアメリカ その他

中東・アフリカ
中東
アフリカ

章の概要
第1章: レポートの対象範囲、歴史と予測期間(2019-2024年、2025-2030年)の世界と地域の市場規模およびCAGRのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な推移をハイレベルで展望しています。
第二章: 様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第3章読者が異なる川下市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの市場規模と発展可能性をカバーするアプリケーション別の様々な市場セグメントの分析を提供します。
第4章mRNA生酵素企業の競争環境、売上高、市場シェアとランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第5章主要企業のプロフィールを提供し、製品紹介、収益、最近の開発状況など、市場における主要企業の基本的な状況を詳細に紹介する。
第6章、第7章、第8章、第9章、第10章北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東&アフリカ、国別の収益。
第11章:この章では、市場力学、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析も紹介する。
第12章調査結果/結論

ページTOPに戻る


目次

1 Market Overview of mRNA Raw Enzyme 1
1.1 mRNA Raw Enzyme Market Overview 1
1.1.1 mRNA Raw Enzyme Product Scope 1
1.1.2 mRNA Raw Enzyme Market Status and Outlook 1
1.2 Global mRNA Raw Enzyme Market Size Overview by Region 2019 VS 2023 VS 2030 3
1.3 Global mRNA Raw Enzyme Market Size by Region (2019-2030) 4
1.3.1 Global mRNA Raw Enzyme Historic Market Size by Region (2019-2024) 4
1.3.2 Global mRNA Raw Enzyme Market Size Forecast by Region (2025-2030) 4
1.4 Key Regions mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.1 North America mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.2 Europe mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.3 Asia-Pacific mRNA Raw Enzyme Market Size (2019-2030) 7
1.4.4 Latin America mRNA Raw Enzyme Market Size (2019-2030) 7
1.4.5 Middle East & Africa mRNA Raw Enzyme Market Size (2019-2030) 8
2 mRNA Raw Enzyme Market by Type 9
2.1 Introduction 9
2.1.1 Capping Enzyme 9
2.1.2 2'-O-Methyltransferase 10
2.1.3 Inorganic Pyrophosphatase 11
2.1.4 Poly (A) Polymerase 12
2.1.5 Rnase Inhibitor 13
2.1.6 RNA Polymerase 14
2.1.7 Restriction Enzyme 15
2.1.8 Dnase I 16
2.1.9 Others 17
2.2 Global mRNA Raw Enzyme Market Size by Type: 2019 VS 2023 VS 2030 18
2.2.1 Global mRNA Raw Enzyme Historic Market Size by Type (2019-2024) 20
2.2.2 Global mRNA Raw Enzyme Forecasted Market Size by Type (2025-2030) 21
2.3 Key Regions Market Size by Type 22
2.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 22
2.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 23
2.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 25
2.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 26
2.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 28
3 mRNA Raw Enzyme Market Overview by Application 30
3.1 Introduction 30
3.1.1 Biopharmaceutical Companies 30
3.1.2 Academic and Research Institutes 31
3.2 Global mRNA Raw Enzyme Market Size by Application: 2019 VS 2023 VS 2030 31
3.2.1 Global mRNA Raw Enzyme Historic Revenue by Application (2019-2024) 32
3.2.2 Global mRNA Raw Enzyme Forecasted Revenue by Application (2025-2030) 33
3.3 Key Regions Market Size by Application 33
3.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 33
3.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 34
3.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 35
3.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 36
3.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 37
4 mRNA Raw Enzyme Competition Analysis by Players 39
4.1 Global mRNA Raw Enzyme Market Size by Players (2019-2024) 39
4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Raw Enzyme as of 2023) 41
4.3 Global Key Players of mRNA Raw Enzyme Head office and Area Served 42
4.4 Global Key Players of mRNA Raw Enzyme Product 43
4.5 Global Key Players of mRNA Raw Enzyme Established Year 44
4.6 Competitive Status 44
4.6.1 mRNA Raw Enzyme Market Concentration Rate 44
4.6.2 Mergers & Acquisitions, Expansion Plans 46
5 Company (Top Players) Profiles 50
5.1 Thermo Fisher 50
5.1.1 Thermo Fisher Profile 50
5.1.2 Thermo Fisher Main Business 50
5.1.3 Thermo Fisher mRNA Raw Enzyme Products, Services and Solutions 51
5.1.4 Thermo Fisher mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 53
5.1.5 Thermo Fisher Recent Developments 53
5.2 NEB 54
5.2.1 NEB Profile 54
5.2.2 NEB Main Business 55
5.2.3 NEB mRNA Raw Enzyme Products, Services and Solutions 55
5.2.4 NEB mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 59
5.2.5 NEB Recent Developments 59
5.3 TriLink Bio Technologies 60
5.3.1 TriLink Bio Technologies Profile 60
5.3.2 TriLink Bio Technologies Main Business 61
5.3.3 TriLink Bio Technologies mRNA Raw Enzyme Products, Services and Solutions 61
5.3.4 TriLink Bio Technologies mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 63
5.3.5 TriLink Bio Technologies Recent Developments 63
5.4 Merck 65
5.4.1 Merck Profile 65
5.4.2 Merck Main Business 66
5.4.3 Merck mRNA Raw Enzyme Products, Services and Solutions 66
5.4.4 Merck mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 68
5.4.5 Merck Recent Developments 68
5.5 Aldevron 69
5.5.1 Aldevron Profile 69
5.5.2 Aldevron Main Business 70
5.5.3 Aldevron mRNA Raw Enzyme Products, Services and Solutions 70
5.5.4 Aldevron mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 71
5.5.5 Aldevron Recent Developments 71
5.6 Qiagen N.V. 72
5.6.1 Qiagen N.V. Profile 72
5.6.2 Qiagen N.V. Main Business 72
5.6.3 Qiagen N.V. mRNA Raw Enzyme Products, Services and Solutions 73
5.6.4 Qiagen N.V. mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 75
5.6.5 Qiagen N.V. Recent Developments 75
5.7 Promega 77
5.7.1 Promega Profile 77
5.7.2 Promega Main Business 77
5.7.3 Promega mRNA Raw Enzyme Products, Services and Solutions 78
5.7.4 Promega mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 79
5.8 Roche CustomBiotech 80
5.8.1 Roche CustomBiotech Profile 80
5.8.2 Roche CustomBiotech Main Business 80
5.8.3 Roche CustomBiotech mRNA Raw Enzyme Products, Services and Solutions 81
5.8.4 Roche CustomBiotech mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 82
5.8.5 Roche CustomBiotech Recent Developments 82
5.9 Takara Bio Inc 83
5.9.1 Takara Bio Inc Profile 83
5.9.2 Takara Bio Inc Main Business 83
5.9.3 Takara Bio Inc mRNA Raw Enzyme Products, Services and Solutions 84
5.9.4 Takara Bio Inc mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 85
5.9.5 Takara Bio Inc Recent Developments 85
5.10 Novoprotein 87
5.10.1 Novoprotein Profile 87
5.10.2 Novoprotein Main Business 87
5.10.3 Novoprotein mRNA Raw Enzyme Products, Services and Solutions 88
5.10.4 Novoprotein mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 91
5.10.5 Novoprotein Recent Developments 91
5.11 Vazyme 92
5.11.1 Vazyme Profile 92
5.11.2 Vazyme Main Business 92
5.11.3 Vazyme mRNA Raw Enzyme Products, Services and Solutions 93
5.11.4 Vazyme mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 95
5.11.5 Vazyme Recent Developments 95
5.12 Hongene Biotech Corporatio 95
5.12.1 Hongene Biotech Corporatio Profile 95
5.12.2 Hongene Biotech Corporatio Main Business 96
5.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Products, Services and Solutions 96
5.12.4 Hongene Biotech Corporatio mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 98
5.12.5 Hongene Biotech Corporatio Recent Developments 98
5.13 Yeasen Biotechnology (Shanghai) 99
5.13.1 Yeasen Biotechnology (Shanghai) Profile 99
5.13.2 Yeasen Biotechnology (Shanghai) Main Business 99
5.13.3 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Products, Services and Solutions 100
5.13.4 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 101
5.13.5 Yeasen Biotechnology (Shanghai) Recent Developments 102
5.14 Kactus Biosystems 102
5.14.1 Kactus Biosystems Profile 102
5.14.2 Kactus Biosystems Main Business 103
5.14.3 Kactus Biosystems mRNA Raw Enzyme Products, Services and Solutions 103
5.14.4 Kactus Biosystems mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 106
5.14.5 Kactus Biosystems Recent Developments 107
6 North America 108
6.1 North America mRNA Raw Enzyme Market Size by Country (2019-2030) 108
6.2 United States 109
6.3 Canada 110
6.4 Mexico 110
7 Europe 111
7.1 Europe mRNA Raw Enzyme Market Size by Country (2019-2030) 111
7.2 Germany 113
7.3 France 113
7.4 U.K. 114
7.5 Italy 114
7.6 Russia 115
7.7 Europe Other 115
8 Asia-Pacific 116
8.1 Asia-Pacific mRNA Raw Enzyme Market Size by Region (2019-2030) 116
8.2 China 118
8.3 Japan 119
8.4 South Korea 119
8.5 Southeast Asia 120
8.6 India 120
8.7 Australia 121
8.8 Asia Pacific Other 121
9 Latin America 122
9.1 Latin America mRNA Raw Enzyme Market Size by Country (2019-2030) 122
9.2 Brazil 123
9.3 Argentina 124
9.4 Latin America Other 124
10 Middle East & Africa 125
10.1 Middle East & Africa mRNA Raw Enzyme Market Size 125
10.2 Middle East 126
10.3 Africa 127
11 mRNA Raw Enzyme Market Dynamics 128
11.1 mRNA Raw Enzyme Industry Trends 128
11.2 mRNA Raw Enzyme Market Drivers 129
11.3 mRNA Raw Enzyme Market Challenges 129
11.4 mRNA Raw Enzyme Market Restraints 130
12 Research Finding/Conclusion 131
13 Methodology and Data Source 133
13.1 Methodology/Research Approach 133
13.1.1 Research Programs/Design 133
13.1.2 Market Size Estimation 134
13.1.3 Market Breakdown and Data Triangulation 135
13.2 Data Source 136
13.2.1 Secondary Sources 136
13.2.2 Primary Sources 137
13.3 Author List 138
13.4 Disclaimer 139

 

ページTOPに戻る


 

Summary

The global market for mRNA Raw Enzyme estimated was at US$ 1767.10 million in the year 2023, is projected to reach a revised size of US$ 1,731.22 million by 2030, growing at a CAGR of 1.42% during the forecast period 2024-2030.
North American market for mRNA Raw Enzyme was valued at $ 640.10 million in 2023 and will reach $ 614.93 million by 2030, at a CAGR of -0.67% during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Raw Enzyme was valued at $ 367.91 million in 2023 and will reach $ 468.47 million by 2030, at a CAGR of 4.83% during the forecast period of 2024 through 2030.
Europe market for mRNA Raw Enzyme was valued at $ 592.33 million in 2023 and will reach $ 565.94 million by 2030, at a CAGR of 1.44% during the forecast period of 2024 through 2030.

This report aims to provide a comprehensive presentation of the global market for mRNA Raw Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Raw Enzyme.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Raw Enzyme market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation
This report covers the mRNA Raw Enzyme segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2019-2024, 2025-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology (Shanghai)
Kactus Biosystems

Segment by Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others

Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Asia-Pacific Other

Europe
Germany
France
U.K.
Italy
Russia
Europe Other

Latin America
Brazil
Argentina
Latin America Other

Middle East & Africa
Middle East
Africa

Chapter Outline
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of mRNA Raw Enzyme companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion



ページTOPに戻る


Table of Contents

1 Market Overview of mRNA Raw Enzyme 1
1.1 mRNA Raw Enzyme Market Overview 1
1.1.1 mRNA Raw Enzyme Product Scope 1
1.1.2 mRNA Raw Enzyme Market Status and Outlook 1
1.2 Global mRNA Raw Enzyme Market Size Overview by Region 2019 VS 2023 VS 2030 3
1.3 Global mRNA Raw Enzyme Market Size by Region (2019-2030) 4
1.3.1 Global mRNA Raw Enzyme Historic Market Size by Region (2019-2024) 4
1.3.2 Global mRNA Raw Enzyme Market Size Forecast by Region (2025-2030) 4
1.4 Key Regions mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.1 North America mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.2 Europe mRNA Raw Enzyme Market Size (2019-2030) 6
1.4.3 Asia-Pacific mRNA Raw Enzyme Market Size (2019-2030) 7
1.4.4 Latin America mRNA Raw Enzyme Market Size (2019-2030) 7
1.4.5 Middle East & Africa mRNA Raw Enzyme Market Size (2019-2030) 8
2 mRNA Raw Enzyme Market by Type 9
2.1 Introduction 9
2.1.1 Capping Enzyme 9
2.1.2 2'-O-Methyltransferase 10
2.1.3 Inorganic Pyrophosphatase 11
2.1.4 Poly (A) Polymerase 12
2.1.5 Rnase Inhibitor 13
2.1.6 RNA Polymerase 14
2.1.7 Restriction Enzyme 15
2.1.8 Dnase I 16
2.1.9 Others 17
2.2 Global mRNA Raw Enzyme Market Size by Type: 2019 VS 2023 VS 2030 18
2.2.1 Global mRNA Raw Enzyme Historic Market Size by Type (2019-2024) 20
2.2.2 Global mRNA Raw Enzyme Forecasted Market Size by Type (2025-2030) 21
2.3 Key Regions Market Size by Type 22
2.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 22
2.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 23
2.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 25
2.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 26
2.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030) 28
3 mRNA Raw Enzyme Market Overview by Application 30
3.1 Introduction 30
3.1.1 Biopharmaceutical Companies 30
3.1.2 Academic and Research Institutes 31
3.2 Global mRNA Raw Enzyme Market Size by Application: 2019 VS 2023 VS 2030 31
3.2.1 Global mRNA Raw Enzyme Historic Revenue by Application (2019-2024) 32
3.2.2 Global mRNA Raw Enzyme Forecasted Revenue by Application (2025-2030) 33
3.3 Key Regions Market Size by Application 33
3.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 33
3.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 34
3.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 35
3.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 36
3.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030) 37
4 mRNA Raw Enzyme Competition Analysis by Players 39
4.1 Global mRNA Raw Enzyme Market Size by Players (2019-2024) 39
4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Raw Enzyme as of 2023) 41
4.3 Global Key Players of mRNA Raw Enzyme Head office and Area Served 42
4.4 Global Key Players of mRNA Raw Enzyme Product 43
4.5 Global Key Players of mRNA Raw Enzyme Established Year 44
4.6 Competitive Status 44
4.6.1 mRNA Raw Enzyme Market Concentration Rate 44
4.6.2 Mergers & Acquisitions, Expansion Plans 46
5 Company (Top Players) Profiles 50
5.1 Thermo Fisher 50
5.1.1 Thermo Fisher Profile 50
5.1.2 Thermo Fisher Main Business 50
5.1.3 Thermo Fisher mRNA Raw Enzyme Products, Services and Solutions 51
5.1.4 Thermo Fisher mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 53
5.1.5 Thermo Fisher Recent Developments 53
5.2 NEB 54
5.2.1 NEB Profile 54
5.2.2 NEB Main Business 55
5.2.3 NEB mRNA Raw Enzyme Products, Services and Solutions 55
5.2.4 NEB mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 59
5.2.5 NEB Recent Developments 59
5.3 TriLink Bio Technologies 60
5.3.1 TriLink Bio Technologies Profile 60
5.3.2 TriLink Bio Technologies Main Business 61
5.3.3 TriLink Bio Technologies mRNA Raw Enzyme Products, Services and Solutions 61
5.3.4 TriLink Bio Technologies mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 63
5.3.5 TriLink Bio Technologies Recent Developments 63
5.4 Merck 65
5.4.1 Merck Profile 65
5.4.2 Merck Main Business 66
5.4.3 Merck mRNA Raw Enzyme Products, Services and Solutions 66
5.4.4 Merck mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 68
5.4.5 Merck Recent Developments 68
5.5 Aldevron 69
5.5.1 Aldevron Profile 69
5.5.2 Aldevron Main Business 70
5.5.3 Aldevron mRNA Raw Enzyme Products, Services and Solutions 70
5.5.4 Aldevron mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 71
5.5.5 Aldevron Recent Developments 71
5.6 Qiagen N.V. 72
5.6.1 Qiagen N.V. Profile 72
5.6.2 Qiagen N.V. Main Business 72
5.6.3 Qiagen N.V. mRNA Raw Enzyme Products, Services and Solutions 73
5.6.4 Qiagen N.V. mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 75
5.6.5 Qiagen N.V. Recent Developments 75
5.7 Promega 77
5.7.1 Promega Profile 77
5.7.2 Promega Main Business 77
5.7.3 Promega mRNA Raw Enzyme Products, Services and Solutions 78
5.7.4 Promega mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 79
5.8 Roche CustomBiotech 80
5.8.1 Roche CustomBiotech Profile 80
5.8.2 Roche CustomBiotech Main Business 80
5.8.3 Roche CustomBiotech mRNA Raw Enzyme Products, Services and Solutions 81
5.8.4 Roche CustomBiotech mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 82
5.8.5 Roche CustomBiotech Recent Developments 82
5.9 Takara Bio Inc 83
5.9.1 Takara Bio Inc Profile 83
5.9.2 Takara Bio Inc Main Business 83
5.9.3 Takara Bio Inc mRNA Raw Enzyme Products, Services and Solutions 84
5.9.4 Takara Bio Inc mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 85
5.9.5 Takara Bio Inc Recent Developments 85
5.10 Novoprotein 87
5.10.1 Novoprotein Profile 87
5.10.2 Novoprotein Main Business 87
5.10.3 Novoprotein mRNA Raw Enzyme Products, Services and Solutions 88
5.10.4 Novoprotein mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 91
5.10.5 Novoprotein Recent Developments 91
5.11 Vazyme 92
5.11.1 Vazyme Profile 92
5.11.2 Vazyme Main Business 92
5.11.3 Vazyme mRNA Raw Enzyme Products, Services and Solutions 93
5.11.4 Vazyme mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 95
5.11.5 Vazyme Recent Developments 95
5.12 Hongene Biotech Corporatio 95
5.12.1 Hongene Biotech Corporatio Profile 95
5.12.2 Hongene Biotech Corporatio Main Business 96
5.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Products, Services and Solutions 96
5.12.4 Hongene Biotech Corporatio mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 98
5.12.5 Hongene Biotech Corporatio Recent Developments 98
5.13 Yeasen Biotechnology (Shanghai) 99
5.13.1 Yeasen Biotechnology (Shanghai) Profile 99
5.13.2 Yeasen Biotechnology (Shanghai) Main Business 99
5.13.3 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Products, Services and Solutions 100
5.13.4 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 101
5.13.5 Yeasen Biotechnology (Shanghai) Recent Developments 102
5.14 Kactus Biosystems 102
5.14.1 Kactus Biosystems Profile 102
5.14.2 Kactus Biosystems Main Business 103
5.14.3 Kactus Biosystems mRNA Raw Enzyme Products, Services and Solutions 103
5.14.4 Kactus Biosystems mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024) 106
5.14.5 Kactus Biosystems Recent Developments 107
6 North America 108
6.1 North America mRNA Raw Enzyme Market Size by Country (2019-2030) 108
6.2 United States 109
6.3 Canada 110
6.4 Mexico 110
7 Europe 111
7.1 Europe mRNA Raw Enzyme Market Size by Country (2019-2030) 111
7.2 Germany 113
7.3 France 113
7.4 U.K. 114
7.5 Italy 114
7.6 Russia 115
7.7 Europe Other 115
8 Asia-Pacific 116
8.1 Asia-Pacific mRNA Raw Enzyme Market Size by Region (2019-2030) 116
8.2 China 118
8.3 Japan 119
8.4 South Korea 119
8.5 Southeast Asia 120
8.6 India 120
8.7 Australia 121
8.8 Asia Pacific Other 121
9 Latin America 122
9.1 Latin America mRNA Raw Enzyme Market Size by Country (2019-2030) 122
9.2 Brazil 123
9.3 Argentina 124
9.4 Latin America Other 124
10 Middle East & Africa 125
10.1 Middle East & Africa mRNA Raw Enzyme Market Size 125
10.2 Middle East 126
10.3 Africa 127
11 mRNA Raw Enzyme Market Dynamics 128
11.1 mRNA Raw Enzyme Industry Trends 128
11.2 mRNA Raw Enzyme Market Drivers 129
11.3 mRNA Raw Enzyme Market Challenges 129
11.4 mRNA Raw Enzyme Market Restraints 130
12 Research Finding/Conclusion 131
13 Methodology and Data Source 133
13.1 Methodology/Research Approach 133
13.1.1 Research Programs/Design 133
13.1.2 Market Size Estimation 134
13.1.3 Market Breakdown and Data Triangulation 135
13.2 Data Source 136
13.2.1 Secondary Sources 136
13.2.2 Primary Sources 137
13.3 Author List 138
13.4 Disclaimer 139

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(ケミカル)の最新刊レポート

本レポートと同じKEY WORD(enzyme)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る